Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.

Real-World Eligibility for HIV Pre-exposure Prophylaxis Among People Who Inject Drugs.
复制标题

DOI:
10.1007/s10461-020-02800-w
复制
发表时间:
2020-08
期刊:
影响因子:
4.4
通讯作者:
Bruneau, Julie
Bruneau, Julie
中科院分区:
医学2区
文献类型:
--
作者:
Picard, Jonathan;Jacka, Brendan;Hoj, Stine;Laverdiere, Emelie;Cox, Joseph;Roy, Elise;Bruneau, Julie

文献摘要

参考文献

相似文献

最近的研究强调了使用暴露前预防(PrEP)预防注射吸毒者(PWID)感染艾滋病毒的有效性和意愿,但对现实世界适用性的了解有限。我们的目的是量化在加拿大蒙特利尔的艾滋病毒阴性PWID(n=718)中的艾滋病毒PrEP的真实世界资格。根据美国疾病控制和预防中心(CDC)指南计算合格性,并根据评估HIV风险(ARCH-PWID)风险筛查工具将其与HIV感染风险进行比较。超过三分之一的参与者(37%)有资格接受艾滋病毒PrEP,其中三分之一的人仅因性风险而合格。根据ARCH-PWID,一半的参与者被认为是艾滋病毒感染的高风险,但这两种方法之间的一致性很差。虽然很大一部分PWID有资格获得HIV-PrEP,但需要更好的工具来识别艾滋病毒感染风险较高的PWID。
Recent studies have highlighted the efficacy of and willingness to use pre-exposure prophylaxis (PrEP) to prevent HIV infection among people who inject drugs (PWID), however knowledge of real-world applicability is limited. We aimed to quantify the real-world eligibility for HIV-PrEP among HIV-negative PWID in Montreal, Canada (n=718). Eligibility was calculated according to US Centers for Disease Control and Prevention (CDC) guidelines and compared to risk of HIV acquisition according to the Assessing Risk for HIV (ARCH-PWID) risk screening tool. Over one-third of participants (37%) were eligible for HIV PrEP, with 1/3 of these eligible due to sexual risk alone. Half of participants were considered high risk of HIV acquisition according to ARCH-PWID, but there was poor agreement between the two measures. Although a large proportion of PWID were eligible for HIV-PrEP, better tools that are context- and location-informed are needed to identify PWID at higher risk of HIV acquisition.
DOI: 10.1097/qad.0000000000001747
发表时间: 2018-03-13
期刊: AIDS (London, England)
影响因子: --
作者:
Fu R;Owens DK;Brandeau ML
通讯作者: Brandeau ML
DOI: 10.1016/j.drugalcdep.2016.12.023
发表时间: 2017-04-01
影响因子: 4.2
作者:
Shrestha R;Karki P;Altice FL;Huedo-Medina TB;Meyer JP;Madden L;Copenhaver M
通讯作者: Copenhaver M
DOI: 10.1007/s10461-016-1627-z
发表时间: 2017-05
期刊: AIDS and behavior
影响因子: 4.4
作者:
Koechlin FM;Fonner VA;Dalglish SL;O'Reilly KR;Baggaley R;Grant RM;Rodolph M;Hodges-Mameletzis I;Kennedy CE
通讯作者: Kennedy CE
DOI: 10.1016/j.drugalcdep.2007.01.004
发表时间: 2007-11-01
影响因子: 4.2
作者:
Kapadia, F.;Latka, M. H.;Garfein, R. S.
通讯作者: Garfein, R. S.
DOI: 10.1016/j.drugpo.2015.04.013
发表时间: 2015-10-01
影响因子: 4.4
作者:
Artenie, Andreea Adelina;Roy, Elise;Bruneau, Julie
通讯作者: Bruneau, Julie